Supplement urolithin a tested for blood sugar boost in older adults
NCT ID NCT06274749
First seen Jun 26, 2026 · Last updated Sep 21, 2026 · Updated 60 times
Summary
This study tests whether urolithin A, a natural supplement, can improve how the body releases insulin and controls blood sugar in healthy adults aged 55 and older with a BMI of 27 or higher. Over 8 weeks, 180 participants will take either urolithin A or a placebo daily. Researchers will measure insulin and hormone responses to sugar drinks, continuous glucose monitoring, and exercise tests.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Urolithin A (a dietary supplement)
- What this could lead to
- If it works, this could point toward a simple supplement to help older adults maintain healthy blood sugar levels and reduce diabetes risk.
- What could go wrong
- This is an early-stage trial in healthy volunteers, so results may not apply to people with diabetes. The supplement may show no benefit over placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 180 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
55 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Provision of signed and dated informed consent form. * Stated willingness to comply with all study procedures and availably for the duration of the study. * Male or female, age \>= 55 years. * Able to speak and read English. (We do not have ready access to interpreters of different languages at the NIA Clinical Unit). * BMI \>= 27. * Ability to take oral medication and be willing to adhere to the daily regimen. * Ability to perform walking and treadmill tests without physical limitations. * In good general health, as evidenced by medical history/physical exam/laboratory results. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * History of diabetes requiring treatment with any glucose lowering drug(s). * Fasting glucose \>= 126 on screening visit. * Is on treatment with an investigational drug or other intervention within 8 weeks of enrollment. * Hospitalization within 12 months for myocardial infarction, coronary revascularization or bypass surgery or stroke. * History of autoimmune disease, e.g., Hashimoto s thyroiditis, Myasthenia Gravis or Rheumatoid Arthritis. * Uncontrolled thyroid disease. * Chronic liver disease indicated by medical history or one of the liver enzymes greater than 2 times the normal range. * History of chronic kidney disease or GFR \<60 mL/min/1.73 m\^2. * Anemia (defined as hemoglobin level \<12 g/dl for men or \< 11 g/dl for women). * Poor venous access. * Uncontrolled hypertension as judged by the Investigator. * History of significant GI disease, e.g., IBS, Crohn s disease. * Active cancer or has had treatment for cancer in the last 1 year. * Medical condition requiring absolute and continuous need for long-term treatment with antibiotics, corticosteroids, immunosuppressors. * Currently pregnant or a nursing mother due to possible changes in hormones and metabolism. * History of, or laboratory evidence of HIV virus infection at Screening Visit. * History of, or laboratory evidence of Hepatitis B or C at Screening Visit. * Positive urine drug screen at Screening Visit (unless taking prescribed medication and at the discretion of the PI). * Reports claustrophobia and/or is not eligible to have an MRI as per the MRI eligibility form. * Weight \>= 300 lbs (MRI scanner weight limit). * Hip or knee replacement or other medical condition that prevents MRI research scans from being performed. * Diagnosed with cognitive impairment that clearly prevents the participant from providing informed consent. * Current smoker or tobacco use in the past year. * History of substance abuse, including marijuana use in the past year. * On average, consumes more than 1 alcoholic drink per day. * Any other condition which in the investigator s opinion may adversely affect the subject s ability to complete the study or its measures or which may pose significant risk to the subject.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy volunteer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
National Institute of Aging, Clinical Research Unit
RECRUITINGBaltimore, Maryland, 21224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental brain drug TAK-935 put to the test in healthy volunteers
- Tracing a Low-THC cannabis extract through the human body
- Can a new injection SGB-9768 pass its first safety test?
- Can a new PET tracer reveal the Body's hidden stress?
- Zapping the brain to shift Decision-Making in depression and aging
- Can a new formula make omega-3 and vitamin D3 supplements work better?